DERMIS

GOAL

Evaluation of the efficacy of photobiomodulation (PBM) therapy in the management of acute radiodermatitis in breast cancer patients

STUDY DESIGN

Pilot trial with breast cancer patients undergoing radiotherapy after a breast sparing surgery at the Jessa Hospital  (NCT01932073) from August 2013 until April 2014

Control group (n=41)	Laser group (n=38)
Standard skin care	Standard skin care
Radiotherapy standard regimen	Radiotherapy standard regimen
/	PBM (2x/week, from dose 40 Gy)

STUDY RESULTS

PBM diminishes the severity of acute radiodermatitis during radiotherapy with 30% and improves the patient's quality of life

PUBLICATIONS

Censabella S, Claes S, Robijns J, Bulens, Mebis J. Photobiomodulation for the management of radiation dermatitis: the DERMIS trial, a pilot study of MLS® laser therapy
in breast cancer patients. Support Care Cancer. 2016 Sep;24(9):3925-33. 
Impact factor 2016: 2.698

PARTNERS